Literature DB >> 16444697

Transcranial application of low-energy laser irradiation improves neurological deficits in rats following acute stroke.

Luis Detaboada1, Sanja Ilic, Sandra Leichliter-Martha, Uri Oron, Amir Oron, Jackson Streeter.   

Abstract

BACKGROUND AND OBJECTIVES: Low-level laser therapy (LLLT) has been shown to have beneficial effects on ischemic skeletal and heart muscles tissues. The aim of the present study was to approve the effectiveness of LLLT treatment at different locations on the brain in acute stroked rats. STUDY DESIGN/
MATERIALS AND METHODS: Stroke was induced in 169 rats that were divided into four groups: control non-laser and three laser-treated groups where laser was employed ipsilateral, contralateral, and both to the side of the induced stroke. Rats were tested for neurological function.
RESULTS: In all three laser-treated groups, a marked and significant improvement in neurological deficits was evident at 14, 21, and 28 days post stroke relative to the non-treated group.
CONCLUSIONS: These observations suggest that LLLT applied at different locations in the skull and in a rather delayed-phase post stroke effectively improves neurological function after acute stroke in rats.

Entities:  

Mesh:

Year:  2006        PMID: 16444697     DOI: 10.1002/lsm.20256

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  44 in total

Review 1.  Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.

Authors:  Paul A Lapchak
Journal:  Expert Rev Med Devices       Date:  2012-01       Impact factor: 3.166

Review 2.  The nuts and bolts of low-level laser (light) therapy.

Authors:  Hoon Chung; Tianhong Dai; Sulbha K Sharma; Ying-Ying Huang; James D Carroll; Michael R Hamblin
Journal:  Ann Biomed Eng       Date:  2011-11-02       Impact factor: 3.934

3.  Dose response effects of 810 nm laser light on mouse primary cortical neurons.

Authors:  Sulbha K Sharma; Gitika B Kharkwal; Mari Sajo; Ying-Ying Huang; Luis De Taboada; Thomas McCarthy; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

Review 4.  Role of low-level laser therapy in neurorehabilitation.

Authors:  Javad T Hashmi; Ying-Ying Huang; Bushra Z Osmani; Sulbha K Sharma; Margaret A Naeser; Michael R Hamblin
Journal:  PM R       Date:  2010-12       Impact factor: 2.298

5.  Safety assessment of trans-tympanic photobiomodulation.

Authors:  Tae-Hyun Moon; Min Young Lee; Jae Yun Jung; Jin-Chul Ahn; So-Young Chang; Phil-Sang Chung; Chung-Ku Rhee; Yoon-Hwan Kim; Myung-Whan Suh
Journal:  Lasers Med Sci       Date:  2016-01-06       Impact factor: 3.161

Review 6.  Taking a light approach to treating acute ischemic stroke patients: transcranial near-infrared laser therapy translational science.

Authors:  Paul A Lapchak
Journal:  Ann Med       Date:  2010-11-01       Impact factor: 4.709

7.  Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro.

Authors:  Ying-Ying Huang; Kazuya Nagata; Clark E Tedford; Michael R Hamblin
Journal:  J Biophotonics       Date:  2013-10-15       Impact factor: 3.207

Review 8.  Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease.

Authors:  Margaret A Naeser; Michael R Hamblin
Journal:  Photomed Laser Surg       Date:  2011-07       Impact factor: 2.796

9.  Comparison of the effects of pulsed and continuous wave light on axonal regeneration in a rat model of spinal cord injury.

Authors:  Xingjia Wu; Helina Moges; Luis DeTaboada; Juanita Anders
Journal:  Lasers Med Sci       Date:  2011-09-10       Impact factor: 3.161

10.  Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study.

Authors:  Margaret A Naeser; Ross Zafonte; Maxine H Krengel; Paula I Martin; Judith Frazier; Michael R Hamblin; Jeffrey A Knight; William P Meehan; Errol H Baker
Journal:  J Neurotrauma       Date:  2014-05-08       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.